In Vivo Toxicology Market Size, Trends, Analysis, and Outlook By Product (Instruments, Consumables), By Test (Acute, Sub-Acute, Sub-Chronic, Chronic Test Type), By Testing Facility (Outsourced Testing Facility, In-House Testing Facility), By Toxicity End Point (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental & reproductive toxicity (DART), Others), By End-User (Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others), by Country, Segment, and Companies, 2024-2032
The global In Vivo Toxicology market size is poised to register 5.9% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global In Vivo Toxicology market across By Product (Instruments, Consumables), By Test (Acute, Sub-Acute, Sub-Chronic, Chronic Test Type), By Testing Facility (Outsourced Testing Facility, In-House Testing Facility), By Toxicity End Point (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental & reproductive toxicity (DART), Others), By End-User (Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others)
The in vivo toxicology market is driven by the increasing need for safety assessment and regulatory compliance in drug development, advancements in animal models and predictive toxicology methods, and the growing complexity of drug candidates and biologics. By 2030, the market is expected to witness significant growth, fueled by innovations in non-animal alternatives, organ-on-a-chip technologies, and in silico modeling approaches. Further, expanding applications in toxicity screening, drug metabolism studies, and chemical risk assessment are anticipated to drive market expansion, enabling pharmaceutical companies, contract research organizations (CROs), and regulatory agencies to evaluate compound safety, predict human toxicology, and accelerate drug discovery through in vivo toxicology solutions that offer accuracy, relevance, and ethical considerations for preclinical testing and regulatory submission in the toxicology market and pharmaceutical industry.
In Vivo Toxicology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The In Vivo Toxicology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of In Vivo Toxicology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the In Vivo Toxicology industry.
Key market trends defining the global In Vivo Toxicology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
In Vivo Toxicology Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The In Vivo Toxicology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support In Vivo Toxicology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the In Vivo Toxicology industry
Leading In Vivo Toxicology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 In Vivo Toxicology companies.
In Vivo Toxicology Market Study- Strategic Analysis Review
The In Vivo Toxicology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The In Vivo Toxicology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
In Vivo Toxicology Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America In Vivo Toxicology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various In Vivo Toxicology market segments. Similarly, Strong market demand is encouraging Canadian In Vivo Toxicology companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico In Vivo Toxicology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe In Vivo Toxicology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European In Vivo Toxicology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European In Vivo Toxicology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific In Vivo Toxicology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for In Vivo Toxicology in Asia Pacific. In particular, China, India, and South East Asian In Vivo Toxicology markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America In Vivo Toxicology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa In Vivo Toxicology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East In Vivo Toxicology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for In Vivo Toxicology.
In Vivo Toxicology Market Company Profiles
The global In Vivo Toxicology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, Bio-Rad Laboratories Inc, Bruker Corp, Charles River Laboratories International Inc, Crown Bioscience Inc, Cyagen Biosciences Inc, Danaher Corp, Envigo, GE Healthcare, genOway S.A., GVK Biosciences Private Ltd, Harbour BioMed, JANVIER LABS, Merck KGaA, Ozgene Pty Ltd, PerkinElmer Inc, PolyGene AG, Shimadzu Corp, Taconic Biosciences Inc, The Jackson Laboratory, Thermo Fisher Scientific Inc, TransCure bioServices, Waters Corp.
Recent In Vivo Toxicology Market Developments
The global In Vivo Toxicology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
In Vivo Toxicology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Instruments
Consumables
By Test
Acute
Sub-Acute
Sub-Chronic
Chronic Test Type
By Testing Facility
Outsourced Testing Facility
In-House Testing Facility
By Toxicity End Point
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental & reproductive toxicity (DART)
Others
By End-User
Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
Geographical Segmentation:
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Bruker Corp
Charles River Laboratories International Inc
Crown Bioscience Inc
Cyagen Biosciences Inc
Danaher Corp
Envigo
GE Healthcare
genOway S.A.
GVK Biosciences Private Ltd
Harbour BioMed
JANVIER LABS
Merck KGaA
Ozgene Pty Ltd
PerkinElmer Inc
PolyGene AG
Shimadzu Corp
Taconic Biosciences Inc
The Jackson Laboratory
Thermo Fisher Scientific Inc
TransCure bioServices
Waters Corp
Formats Available: Excel, PDF, and PPT
The in vivo toxicology market is driven by the increasing need for safety assessment and regulatory compliance in drug development, advancements in animal models and predictive toxicology methods, and the growing complexity of drug candidates and biologics. By 2030, the market is expected to witness significant growth, fueled by innovations in non-animal alternatives, organ-on-a-chip technologies, and in silico modeling approaches. Further, expanding applications in toxicity screening, drug metabolism studies, and chemical risk assessment are anticipated to drive market expansion, enabling pharmaceutical companies, contract research organizations (CROs), and regulatory agencies to evaluate compound safety, predict human toxicology, and accelerate drug discovery through in vivo toxicology solutions that offer accuracy, relevance, and ethical considerations for preclinical testing and regulatory submission in the toxicology market and pharmaceutical industry.
In Vivo Toxicology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The In Vivo Toxicology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of In Vivo Toxicology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the In Vivo Toxicology industry.
Key market trends defining the global In Vivo Toxicology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
In Vivo Toxicology Market Segmentation- Industry Share, Market Size, and Outlook to 2032
The In Vivo Toxicology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support In Vivo Toxicology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the In Vivo Toxicology industry
Leading In Vivo Toxicology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 In Vivo Toxicology companies.
In Vivo Toxicology Market Study- Strategic Analysis Review
The In Vivo Toxicology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The In Vivo Toxicology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.
In Vivo Toxicology Country Analysis and Revenue Outlook to 2032
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.
North America In Vivo Toxicology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various In Vivo Toxicology market segments. Similarly, Strong market demand is encouraging Canadian In Vivo Toxicology companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico In Vivo Toxicology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe In Vivo Toxicology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European In Vivo Toxicology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European In Vivo Toxicology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific In Vivo Toxicology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for In Vivo Toxicology in Asia Pacific. In particular, China, India, and South East Asian In Vivo Toxicology markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.
Latin America In Vivo Toxicology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa In Vivo Toxicology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East In Vivo Toxicology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for In Vivo Toxicology.
In Vivo Toxicology Market Company Profiles
The global In Vivo Toxicology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Agilent Technologies Inc, Bio-Rad Laboratories Inc, Bruker Corp, Charles River Laboratories International Inc, Crown Bioscience Inc, Cyagen Biosciences Inc, Danaher Corp, Envigo, GE Healthcare, genOway S.A., GVK Biosciences Private Ltd, Harbour BioMed, JANVIER LABS, Merck KGaA, Ozgene Pty Ltd, PerkinElmer Inc, PolyGene AG, Shimadzu Corp, Taconic Biosciences Inc, The Jackson Laboratory, Thermo Fisher Scientific Inc, TransCure bioServices, Waters Corp.
Recent In Vivo Toxicology Market Developments
The global In Vivo Toxicology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
In Vivo Toxicology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Instruments
Consumables
By Test
Acute
Sub-Acute
Sub-Chronic
Chronic Test Type
By Testing Facility
Outsourced Testing Facility
In-House Testing Facility
By Toxicity End Point
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental & reproductive toxicity (DART)
Others
By End-User
Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Bruker Corp
Charles River Laboratories International Inc
Crown Bioscience Inc
Cyagen Biosciences Inc
Danaher Corp
Envigo
GE Healthcare
genOway S.A.
GVK Biosciences Private Ltd
Harbour BioMed
JANVIER LABS
Merck KGaA
Ozgene Pty Ltd
PerkinElmer Inc
PolyGene AG
Shimadzu Corp
Taconic Biosciences Inc
The Jackson Laboratory
Thermo Fisher Scientific Inc
TransCure bioServices
Waters Corp
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 In Vivo Toxicology Market Overview and Key Findings, 2024
1.2 In Vivo Toxicology Market Size and Growth Outlook, 2021- 2030
1.3 In Vivo Toxicology Market Growth Opportunities to 2030
1.4 Key In Vivo Toxicology Market Trends and Challenges
1.4.1 In Vivo Toxicology Market Drivers and Trends
1.4.2 In Vivo Toxicology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading In Vivo Toxicology Companies
2. IN VIVO TOXICOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 In Vivo Toxicology Market Size Outlook, USD Million, 2021- 2030
2.2 In Vivo Toxicology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IN VIVO TOXICOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IN VIVO TOXICOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Instruments
Consumables
By Test
Acute
Sub-Acute
Sub-Chronic
Chronic Test Type
By Testing Facility
Outsourced Testing Facility
In-House Testing Facility
By Toxicity End Point
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental & reproductive toxicity (DART)
Others
By End-User
Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific In Vivo Toxicology Market, 2025
5.2 Asia Pacific In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe In Vivo Toxicology Market, 2025
5.5 Europe In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.6 Europe In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America In Vivo Toxicology Market, 2025
5.8 North America In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.9 North America In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America In Vivo Toxicology Market, 2025
5.11 South America Pacific In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.12 South America In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa In Vivo Toxicology Market, 2025
5.14 Middle East Africa In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US In Vivo Toxicology Market Size Outlook and Revenue Growth Forecasts
6.2 US In Vivo Toxicology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada In Vivo Toxicology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico In Vivo Toxicology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany In Vivo Toxicology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France In Vivo Toxicology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK In Vivo Toxicology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain In Vivo Toxicology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy In Vivo Toxicology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe In Vivo Toxicology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China In Vivo Toxicology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India In Vivo Toxicology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan In Vivo Toxicology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea In Vivo Toxicology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia In Vivo Toxicology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia In Vivo Toxicology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific In Vivo Toxicology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil In Vivo Toxicology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina In Vivo Toxicology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America In Vivo Toxicology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East In Vivo Toxicology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa In Vivo Toxicology Industry Drivers and Opportunities
7. IN VIVO TOXICOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IN VIVO TOXICOLOGY COMPANY PROFILES
8.1 Profiles of Leading In Vivo Toxicology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Bruker Corp
Charles River Laboratories International Inc
Crown Bioscience Inc
Cyagen Biosciences Inc
Danaher Corp
Envigo
GE Healthcare
genOway S.A.
GVK Biosciences Private Ltd
Harbour BioMed
JANVIER LABS
Merck KGaA
Ozgene Pty Ltd
PerkinElmer Inc
PolyGene AG
Shimadzu Corp
Taconic Biosciences Inc
The Jackson Laboratory
Thermo Fisher Scientific Inc
TransCure bioServices
Waters Corp.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 In Vivo Toxicology Market Overview and Key Findings, 2024
1.2 In Vivo Toxicology Market Size and Growth Outlook, 2021- 2030
1.3 In Vivo Toxicology Market Growth Opportunities to 2030
1.4 Key In Vivo Toxicology Market Trends and Challenges
1.4.1 In Vivo Toxicology Market Drivers and Trends
1.4.2 In Vivo Toxicology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading In Vivo Toxicology Companies
2. IN VIVO TOXICOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 In Vivo Toxicology Market Size Outlook, USD Million, 2021- 2030
2.2 In Vivo Toxicology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. IN VIVO TOXICOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. IN VIVO TOXICOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Instruments
Consumables
By Test
Acute
Sub-Acute
Sub-Chronic
Chronic Test Type
By Testing Facility
Outsourced Testing Facility
In-House Testing Facility
By Toxicity End Point
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental & reproductive toxicity (DART)
Others
By End-User
Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Others
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific In Vivo Toxicology Market, 2025
5.2 Asia Pacific In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe In Vivo Toxicology Market, 2025
5.5 Europe In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.6 Europe In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America In Vivo Toxicology Market, 2025
5.8 North America In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.9 North America In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America In Vivo Toxicology Market, 2025
5.11 South America Pacific In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.12 South America In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa In Vivo Toxicology Market, 2025
5.14 Middle East Africa In Vivo Toxicology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa In Vivo Toxicology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US In Vivo Toxicology Market Size Outlook and Revenue Growth Forecasts
6.2 US In Vivo Toxicology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada In Vivo Toxicology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico In Vivo Toxicology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany In Vivo Toxicology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France In Vivo Toxicology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK In Vivo Toxicology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain In Vivo Toxicology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy In Vivo Toxicology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe In Vivo Toxicology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China In Vivo Toxicology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India In Vivo Toxicology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan In Vivo Toxicology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea In Vivo Toxicology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia In Vivo Toxicology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia In Vivo Toxicology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific In Vivo Toxicology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil In Vivo Toxicology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina In Vivo Toxicology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America In Vivo Toxicology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East In Vivo Toxicology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa In Vivo Toxicology Industry Drivers and Opportunities
7. IN VIVO TOXICOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. IN VIVO TOXICOLOGY COMPANY PROFILES
8.1 Profiles of Leading In Vivo Toxicology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Agilent Technologies Inc
Bio-Rad Laboratories Inc
Bruker Corp
Charles River Laboratories International Inc
Crown Bioscience Inc
Cyagen Biosciences Inc
Danaher Corp
Envigo
GE Healthcare
genOway S.A.
GVK Biosciences Private Ltd
Harbour BioMed
JANVIER LABS
Merck KGaA
Ozgene Pty Ltd
PerkinElmer Inc
PolyGene AG
Shimadzu Corp
Taconic Biosciences Inc
The Jackson Laboratory
Thermo Fisher Scientific Inc
TransCure bioServices
Waters Corp.
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
